Melexis NV Logo

Melexis NV

MELE.BR

(4.0)
Stock Price

57,80 EUR

23.49% ROA

36.94% ROE

13.83x PER

Market Cap.

2.886.580.000,00 EUR

41.7% DER

5.18% Yield

21.15% NPM

Melexis NV Stock Analysis

Melexis NV Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Melexis NV Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (41.07%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a low debt to equity ratio (24%), which means it has a small amount of debt compared to the ownership it holds

4 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 Net Profit Growth

The net profit of this company has steadily increased over the last five years, showcasing a favorable financial performance and making it an enticing option for investors seeking growth potential.

6 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

7 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

8 Dividend Growth

Investors can take confidence in the company's impressive track record of annual dividend growth over the last three years, showcasing a commitment to providing higher returns.

9 Buffet Intrinsic Value

The company's stock seems undervalued (516) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

10 PBV

The stock's elevated P/BV ratio (5.96x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

11 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

Melexis NV Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Melexis NV Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Melexis NV Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Melexis NV Revenue
Year Revenue Growth
2002 118.191.252
2003 133.549.184 11.5%
2004 148.752.000 10.22%
2005 173.674.260 14.35%
2006 201.501.718 13.81%
2007 204.055.168 1.25%
2008 185.549.343 -9.97%
2009 128.890.440 -43.96%
2010 219.426.785 41.26%
2011 230.661.497 4.87%
2012 247.040.763 6.63%
2013 275.352.454 10.28%
2014 332.407.655 17.16%
2015 400.135.935 16.93%
2016 456.284.989 12.31%
2017 511.661.446 10.82%
2018 569.369.915 10.14%
2019 486.861.655 -16.95%
2020 507.517.322 4.07%
2021 643.786.021 21.17%
2022 836.157.000 23.01%
2023 994.204.000 15.9%
2023 964.298.000 -3.1%
2024 982.913.528 1.89%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Melexis NV Research and Development Expenses
Year Research and Development Expenses Growth
2002 16.614.561
2003 18.749.812 11.39%
2004 6.648.000 -182.04%
2005 24.987.990 73.4%
2006 27.603.546 9.48%
2007 29.792.249 7.35%
2008 29.524.991 -0.91%
2009 26.122.036 -13.03%
2010 29.700.695 12.05%
2011 34.341.998 13.51%
2012 38.868.794 11.65%
2013 41.373.287 6.05%
2014 45.433.627 8.94%
2015 56.737.053 19.92%
2016 63.989.373 11.33%
2017 69.483.472 7.91%
2018 21.131.815 -228.81%
2019 79.557.736 73.44%
2020 77.690.691 -2.4%
2021 78.387.958 0.89%
2022 90.211.000 13.11%
2023 105.984.000 14.88%
2023 106.732.000 0.7%
2024 106.131.076 -0.57%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Melexis NV General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 5.081.029
2003 5.043.344 -0.75%
2004 793.000 -535.98%
2005 7.898.155 89.96%
2006 9.789.574 19.32%
2007 11.003.868 11.04%
2008 10.743.975 -2.42%
2009 9.790.196 -9.74%
2010 10.519.214 6.93%
2011 12.539.615 16.11%
2012 7.842.761 -59.89%
2013 8.982.011 12.68%
2014 10.082.267 10.91%
2015 11.337.246 11.07%
2016 12.275.476 7.64%
2017 13.439.066 8.66%
2018 21.209.245 36.64%
2019 15.313.023 -38.5%
2020 15.234.425 -0.52%
2021 15.912.104 4.26%
2022 40.887.000 61.08%
2023 48.016.000 14.85%
2023 25.379.285 -89.19%
2024 52.025.592 51.22%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Melexis NV EBITDA
Year EBITDA Growth
2002 42.511.546
2003 45.362.860 6.29%
2004 42.331.100 -7.16%
2005 46.168.684 8.31%
2006 53.262.251 13.32%
2007 52.561.695 -1.33%
2008 48.543.191 -8.28%
2009 20.561.727 -136.09%
2010 67.799.155 69.67%
2011 72.041.712 5.89%
2012 71.613.477 -0.6%
2013 80.423.741 10.95%
2014 113.852.157 29.36%
2015 132.888.535 14.33%
2016 139.046.459 4.43%
2017 166.525.024 16.5%
2018 178.692.992 6.81%
2019 118.803.881 -50.41%
2020 123.134.657 3.52%
2021 189.420.740 34.99%
2022 271.696.000 30.28%
2023 328.648.000 17.33%
2023 306.420.000 -7.25%
2024 306.802.960 0.12%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Melexis NV Gross Profit
Year Gross Profit Growth
2002 50.371.961
2003 57.183.971 11.91%
2004 73.185.000 21.86%
2005 72.281.283 -1.25%
2006 84.601.546 14.56%
2007 84.801.801 0.24%
2008 75.916.859 -11.7%
2009 48.215.092 -57.45%
2010 102.251.028 52.85%
2011 108.209.997 5.51%
2012 115.476.180 6.29%
2013 127.529.284 9.45%
2014 161.305.953 20.94%
2015 192.121.392 16.04%
2016 208.548.190 7.88%
2017 235.396.396 11.41%
2018 261.136.057 9.86%
2019 196.233.854 -33.07%
2020 197.988.054 0.89%
2021 273.600.526 27.64%
2022 374.678.000 26.98%
2023 457.968.000 18.19%
2023 440.221.000 -4.03%
2024 435.063.604 -1.19%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Melexis NV Net Profit
Year Net Profit Growth
2002 21.640.134
2003 24.578.657 11.96%
2004 24.876.050 1.2%
2005 28.156.849 11.65%
2006 34.526.601 18.45%
2007 37.084.034 6.9%
2008 22.451.406 -65.17%
2009 -3.989.054 662.83%
2010 48.612.137 108.21%
2011 45.893.624 -5.92%
2012 51.529.359 10.94%
2013 55.213.550 6.67%
2014 84.994.225 35.04%
2015 99.071.482 14.21%
2016 96.256.883 -2.92%
2017 110.954.678 13.25%
2018 115.451.278 3.89%
2019 60.255.234 -91.6%
2020 69.299.312 13.05%
2021 131.108.216 47.14%
2022 197.152.664 33.5%
2023 227.256.000 13.25%
2023 209.463.394 -8.49%
2024 196.273.732 -6.72%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Melexis NV Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 1 0%
2004 1 0%
2005 1 0%
2006 1 0%
2007 1 0%
2008 1 0%
2009 0 0%
2010 1 100%
2011 1 0%
2012 1 0%
2013 1 0%
2014 2 50%
2015 2 0%
2016 2 0%
2017 3 0%
2018 3 0%
2019 2 -100%
2020 2 0%
2021 3 66.67%
2022 5 25%
2023 6 20%
2023 5 0%
2024 5 -25%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Melexis NV Free Cashflow
Year Free Cashflow Growth
2002 7.616.185
2003 11.556.690 34.1%
2004 33.104.000 65.09%
2005 24.422.021 -35.55%
2006 21.733.770 -12.37%
2007 18.097.163 -20.09%
2008 5.208.866 -247.43%
2009 8.730.742 40.34%
2010 29.669.660 70.57%
2011 43.599.563 31.95%
2012 34.706.724 -25.62%
2013 48.292.419 28.13%
2014 71.300.021 32.27%
2015 74.717.887 4.57%
2016 79.177.371 5.63%
2017 66.888.564 -18.37%
2018 23.426.439 -185.53%
2019 67.768.295 65.43%
2020 70.925.266 4.45%
2021 103.144.287 31.24%
2022 147.953.000 30.29%
2023 -90.887.000 262.79%
2023 5.367.000 1793.44%
2024 44.784.140 88.02%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Melexis NV Operating Cashflow
Year Operating Cashflow Growth
2002 22.201.450
2003 22.860.305 2.88%
2004 43.885.000 47.91%
2005 33.755.840 -30.01%
2006 37.224.098 9.32%
2007 33.238.043 -11.99%
2008 26.889.819 -23.61%
2009 19.702.308 -36.48%
2010 45.046.592 56.26%
2011 58.212.169 22.62%
2012 55.455.908 -4.97%
2013 70.824.525 21.7%
2014 94.994.117 25.44%
2015 114.998.453 17.4%
2016 107.951.382 -6.53%
2017 113.305.860 4.73%
2018 99.722.301 -13.62%
2019 94.400.227 -5.64%
2020 95.760.709 1.42%
2021 142.232.430 32.67%
2022 187.837.000 24.28%
2023 3.903.000 -4712.63%
2023 33.397.000 88.31%
2024 55.313.749 39.62%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Melexis NV Capital Expenditure
Year Capital Expenditure Growth
2002 14.585.265
2003 11.303.615 -29.03%
2004 10.781.000 -4.85%
2005 9.333.819 -15.5%
2006 15.490.328 39.74%
2007 15.140.880 -2.31%
2008 21.680.953 30.17%
2009 10.971.566 -97.61%
2010 15.376.932 28.65%
2011 14.612.606 -5.23%
2012 20.749.184 29.58%
2013 22.532.106 7.91%
2014 23.694.096 4.9%
2015 40.280.566 41.18%
2016 28.774.011 -39.99%
2017 46.417.296 38.01%
2018 76.295.862 39.16%
2019 26.631.932 -186.48%
2020 24.835.443 -7.23%
2021 39.088.143 36.46%
2022 39.884.000 2%
2023 94.790.000 57.92%
2023 28.030.000 -238.17%
2024 10.529.609 -166.2%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Melexis NV Equity
Year Equity Growth
2002 86.867.431
2003 86.153.411 -0.83%
2004 54.869.000 -57.02%
2005 61.778.468 11.18%
2006 69.614.701 11.26%
2007 78.146.728 10.92%
2008 61.527.114 -27.01%
2009 59.854.165 -2.8%
2010 95.455.221 37.3%
2011 107.120.697 10.89%
2012 129.277.100 17.14%
2013 157.638.541 17.99%
2014 201.361.099 21.71%
2015 242.510.831 16.97%
2016 262.464.664 7.6%
2017 294.302.696 10.82%
2018 326.006.277 9.72%
2019 299.070.320 -9.01%
2020 314.776.150 4.99%
2021 389.056.448 19.09%
2022 482.083.410 19.3%
2023 553.104.000 12.84%
2023 551.067.410 -0.37%
2024 553.586.233 0.46%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Melexis NV Assets
Year Assets Growth
2002 113.041.642
2003 121.077.672 6.64%
2004 122.739.360 1.35%
2005 118.945.531 -3.19%
2006 169.665.619 29.89%
2007 168.988.222 -0.4%
2008 157.440.548 -7.33%
2009 154.252.254 -2.07%
2010 180.478.976 14.53%
2011 178.103.189 -1.33%
2012 195.570.480 8.93%
2013 214.816.999 8.96%
2014 256.773.396 16.34%
2015 306.770.078 16.3%
2016 358.165.449 14.35%
2017 403.360.590 11.2%
2018 428.019.465 5.76%
2019 418.609.854 -2.25%
2020 433.412.325 3.42%
2021 461.180.495 6.02%
2022 580.233.000 20.52%
2023 798.671.000 27.35%
2023 866.081.000 7.78%
2024 891.098.131 2.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Melexis NV Liabilities
Year Liabilities Growth
2002 26.174.211
2003 34.924.261 25.05%
2004 67.870.000 48.54%
2005 57.167.063 -18.72%
2006 100.050.918 42.86%
2007 90.841.494 -10.14%
2008 95.913.434 5.29%
2009 94.398.089 -1.61%
2010 85.023.755 -11.03%
2011 70.982.492 -19.78%
2012 66.293.380 -7.07%
2013 57.178.458 -15.94%
2014 55.412.297 -3.19%
2015 64.259.247 13.77%
2016 95.700.785 32.85%
2017 109.057.894 12.25%
2018 102.013.188 -6.91%
2019 119.539.534 14.66%
2020 118.636.175 -0.76%
2021 72.124.047 -64.49%
2022 98.150.000 26.52%
2023 245.567.000 60.03%
2023 315.014.000 22.05%
2024 337.511.898 6.67%

Melexis NV Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
24.42
Net Income per Share
5.16
Price to Earning Ratio
13.83x
Price To Sales Ratio
2.93x
POCF Ratio
18.85
PFCF Ratio
41.07
Price to Book Ratio
5.21
EV to Sales
3.13
EV Over EBITDA
10.06
EV to Operating CashFlow
20.15
EV to FreeCashFlow
43.91
Earnings Yield
0.07
FreeCashFlow Yield
0.02
Market Cap
2,89 Bil.
Enterprise Value
3,09 Bil.
Graham Number
39.9
Graham NetNet
-1.47

Income Statement Metrics

Net Income per Share
5.16
Income Quality
0.73
ROE
0.37
Return On Assets
0.23
Return On Capital Employed
0.33
Net Income per EBT
0.83
EBT Per Ebit
0.96
Ebit per Revenue
0.26
Effective Tax Rate
0.17

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0.11
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.45
Operating Profit Margin
0.26
Pretax Profit Margin
0.25
Net Profit Margin
0.21

Dividends

Dividend Yield
0.05
Dividend Yield %
5.18
Payout Ratio
0.72
Dividend Per Share
3.7

Operating Metrics

Operating Cashflow per Share
3.79
Free CashFlow per Share
1.74
Capex to Operating CashFlow
0.54
Capex to Revenue
0.08
Capex to Depreciation
1.8
Return on Invested Capital
0.28
Return on Tangible Assets
0.23
Days Sales Outstanding
54.78
Days Payables Outstanding
41.72
Days of Inventory on Hand
172.05
Receivables Turnover
6.66
Payables Turnover
8.75
Inventory Turnover
2.12
Capex per Share
2.05

Balance Sheet

Cash per Share
0,96
Book Value per Share
13,70
Tangible Book Value per Share
13.63
Shareholders Equity per Share
13.7
Interest Debt per Share
5.94
Debt to Equity
0.42
Debt to Assets
0.26
Net Debt to EBITDA
0.65
Current Ratio
4.7
Tangible Asset Value
0,55 Bil.
Net Current Asset Value
0,11 Bil.
Invested Capital
570542646
Working Capital
0,36 Bil.
Intangibles to Total Assets
0
Average Receivables
0,14 Bil.
Average Payables
0,06 Bil.
Average Inventory
257290494
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Melexis NV Dividends
Year Dividends Growth
2002 1
2003 1 0%
2004 1 0%
2005 1 0%
2006 1 0%
2007 1 0%
2008 1 0%
2009 0 0%
2010 0 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 100%
2015 1 0%
2016 2 0%
2017 2 50%
2018 2 0%
2019 2 0%
2020 2 0%
2021 2 0%
2022 3 0%
2023 4 33.33%
2024 2 -50%

Melexis NV Profile

About Melexis NV

Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN/CAN system basis, NFC/RFID, radio-frequency receiver and transmitter, and switch controller ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.

CEO
Mr. Marc Biron
Employee
1.951
Address
Rozendaalstraat 12
Ieper, 8900

Melexis NV Executives & BODs

Melexis NV Executives & BODs
# Name Age
1 Ms. Karen Van Griensven
Chief Financial Officer
70
2 Mr. Vincent Hiligsmann
Vice President of Corporate Strategy - Global Sales, Brand & Communication
70
3 Mr. Marc Biron
MD, Chief Executive Officer & Director
70
4 Ms. Veerle Lozie
Chief Operations & Information Officer
70

Melexis NV Competitors

ageas SA/NV Logo
ageas SA/NV

AGS.BR

(2.2)
Barco NV Logo
Barco NV

BAR.BR

(2.8)
Umicore SA Logo
Umicore SA

UMI.BR

(2.8)